Business
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.co
About this update from Iradimed Corporation
[{"type":"image","alt":"iRadimed Corporation","displaySize":"","headline":null,"caption":"iRadimed Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/901275c4c3f8ac96e1bc72dd8ecb4852"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rRJ3kbDXnYeNAok33IB5bg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY0/https://media.zenfs.com/en/globenewswire.com/901275c4c3f8ac96e1bc72dd8ecb4852","width":300,"height":46}},"lazy":false},{"type":"text","content":"ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.","length":373,"tagName":"p"},{"type":"text","content":"Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI7676b33322324840ad2b154cc8e65b88. Once registered, a dial-in number, unique pin, and instructions will be provided to participants.","length":275,"tagName":"p"},{"type":"text","content":"The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following the completion of the call.","length":231,"tagName":"p"},{"type":"text","content":"About IRADIMED CORPORATION","length":26,"tagName":"p"},{"type":"text","content":"IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed wi...